For the first time in about 30 years, groundbreaking anti-obesity drugs have appeared in succession (the last new drug was released in the 1990s), and the period from 2024 to 2025 marks the beginning of a new era that can be called the "Year One of Obesity Treatment in Japan." New drugs in the GLP-1 receptor agonist class, described as "game changers" overseas in countries like the United States, have now become available for use under insurance in Japan
Click the links above to explore the research and click here to follow me on X for all the latest health and performance news hot off the press
Federal Institute of Risk Assessment (BfM), Germany, November 11, 2006
Kosmaczewska A, Swierkot J, Ciszak L, Wiland P
It can also cause increased pain, bruising, bleeding, and the formation of hard lumps under the skin
Nausea management strategies include eating smaller meals, avoiding high-fat foods around injection time, staying well-hydrated, and taking the injection at a time that positions peak nausea during sleep hours